Word

JUBAFIL

Status

Dead

Status Code

606

Status Date

Monday, January 11, 2021

Serial Number

88227610

Mark Type

4000

Filing Date

Thursday, December 13, 2018

Published for Opposition

Tuesday, April 16, 2019

Abandoned Date

Monday, January 11, 2021

Trademark Owner History

Teva Pharmaceuticals USA, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacement medications

Trademark Events

Jan 11, 2021

Abandonment Notice E-Mailed - No Use Statement Filed

Jan 11, 2021

Abandonment - No Use Statement Filed

Jun 10, 2020

Notice Of Approval Of Extension Request E-Mailed

Jun 8, 2020

Extension 2 Granted

Jun 8, 2020

Extension 2 Filed

Jun 8, 2020

Teas Extension Received

Dec 4, 2019

Teas Change Of Correspondence Received

Dec 6, 2019

Notice Of Approval Of Extension Request E-Mailed

Dec 4, 2019

Extension 1 Granted

Dec 4, 2019

Extension 1 Filed

Dec 4, 2019

Teas Extension Received

Jun 11, 2019

Noa E-Mailed - Sou Required From Applicant

Apr 16, 2019

Official Gazette Publication Confirmation E-Mailed

Apr 16, 2019

Published For Opposition

Mar 27, 2019

Notification Of Notice Of Publication E-Mailed

Mar 8, 2019

Approved For Pub - Principal Register

Mar 8, 2019

Assigned To Examiner

Jan 5, 2019

New Application Office Supplied Data Entered In Tram

Dec 17, 2018

New Application Entered In Tram